LGALS3BP is a novel and potential biomarker in clear cell renal cell carcinoma

Lei Li; Sen Qin; Hongwei Tan; Jiexue Zhou

doi:doi:10.18632/aging.205578

← Back

Research Paper Volume 16, Issue 4 pp 4033—4051

LGALS3BP is a novel and potential biomarker in clear cell renal cell carcinoma

Figure 3. The prognostic value of LGALS3BP in KIRC. (A) Disease-free survival in ccRCC patients with high or low LGALS3BP expression (GEPIA2). (B) Overall survival in ccRCC patients with high or low expression of LGALS3BP (GEPIA2).